Patent assignee · FR · COMPANY

NANOBIOTIX

🏢 View company profile →
16Patents
16Active
16Granted
51Portfolio score

Filing activity: May 9, 2005 → Sep 13, 2018 · 1 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8845507B2 Inorganic nanoparticles of high density to destroy cells in-vivo Emerging Cross-Sectional Technologies 13 Active
US9162079B2 Activatable particles, preparations and uses Human Necessities 7 Active
US10413509B2 Pharmaceutical composition, preparation and uses thereof Emerging Cross-Sectional Technologies 5 Active
US9700621B2 Metallic nanoparticles, preparation and uses thereof Human Necessities 3 Active
US10588987B2 Compositions and methods for use in medical diagnosis Human Necessities 3 Active
US10098952B2 Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer Human Necessities 3 Active
US10391058B2 Pharmaceutical composition combining at least two distinct nanoparticles and a pharmaceutical compound, preparation and uses thereof Emerging Cross-Sectional Technologies 3 Active
US9433800B2 Activatable particles, preparation and uses Human Necessities 2 Active
US11020480B2 Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer Human Necessities 1 Active
US10945965B2 Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof Human Necessities 1 Active
US11229705B2 Coated nanoparticles for use for modulating electrical polarization of neurons Human Necessities 1 Active
US10391174B2 Metallic nanoparticles, preparation and uses thereof Human Necessities 1 Active
US9956175B2 Nanoparticles delivery systems, preparation and uses thereof Human Necessities 1 Active
US11096962B2 Nanoparticles for use as a therapeutic vaccine Human Necessities 0 Active
US10265406B2 Pharmaceutical composition comprising nanoparticles, preparation and uses thereof Human Necessities 0 Active
US10064962B2 Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles Physics 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.